16 Podcast Episodes
FDA Accelerated Approvals and COI Phenomenons With Bishal Gyawali
FDA Accelerated Approvals and COI Phenomenons With Bishal Gyawali
Chadi welcomes back Bishal Gyawali (@oncology_bg), MD, PhD, Queen’s University Cancer Research Institute (Canada), to th... Read more
18 Jan 2022
•
58mins
The OJC Episode 39 with Bishal Gyawali: Chewing the ASCO 2021 Fat
The OJC Episode 39 with Bishal Gyawali: Chewing the ASCO 2021 Fat
The Oncology Journal Club - Delivering Oncology News DifferentlyThe Oncology Podcast, brought to you by Oncology News Au... Read more
29 Jun 2021
•
35mins
3.80 ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) with Drs. Bishal Gyawali and Nathan Cherny
3.80 ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) with Drs. Bishal Gyawali and Nathan Cherny
Today we sit down with Dr. Bishal Gyawali of Queen's University in Kingston, Ontario, Canada and with Dr. Nathan Cherny ... Read more
20 May 2021
•
54mins
Optimizing Clinical Trial Design with Bishal Gyawali
Optimizing Clinical Trial Design with Bishal Gyawali
Bishal Gyawali (@oncology_bg), MD, PhD, Queen’s University Cancer Research Institute (Canada), joins the show to discuss... Read more
18 May 2021
•
1hr 11mins
Dr. Bishal Gyawali on Cancer Drugs, Clinical Benefits & Reimbursement Rates
Dr. Bishal Gyawali on Cancer Drugs, Clinical Benefits & Reimbursement Rates
Dr. Bishal Gyawali, Assistant Professor, Department of Public Health Sciences and Clinical Fellow, Department of Oncolog... Read more
28 Feb 2021
•
45mins
Dr. Bishal Gyawali on Current Cancer Research Efforts & the Failure to Match the Global Burden of Cancer Deaths
Dr. Bishal Gyawali on Current Cancer Research Efforts & the Failure to Match the Global Burden of Cancer Deaths
Dr. Bishal Gyawali, Assistant Professor, Department of Public Health Sciences and Clinical Fellow, Department of Oncolog... Read more
3 Feb 2021
•
28mins
EP289: The Right Amount of Oncology Screening and Care—In a Pandemic and Not in a Pandemic, With Bishal Gyawali, MD, PhD
EP289: The Right Amount of Oncology Screening and Care—In a Pandemic and Not in a Pandemic, With Bishal Gyawali, MD, PhD
You may or may not know (I don’t know why you would, honestly), but I speak Swedish. I mention this because there’s this... Read more
20 Aug 2020
•
35mins
3.04 Listener Questions & MedTwitter and Risk-Benefit Profile of Ramucirumab with Dr. Bishal Gyawali
3.04 Listener Questions & MedTwitter and Risk-Benefit Profile of Ramucirumab with Dr. Bishal Gyawali
This week we respond to several questions sent in by listeners and then we interview Dr. Bishal Gyawali of Queen's Unive... Read more
24 Jul 2020
•
1hr 31mins
2.38 KEYNOTE-048, Academic Currency, & Trials in Low/Mid-Income Countries with Dr. Bishal Gyawali
2.38 KEYNOTE-048, Academic Currency, & Trials in Low/Mid-Income Countries with Dr. Bishal Gyawali
We start this episode by diving deep into KEYNOTE-048, the randomized, open-label, phase 3 study of pembrolizumab alone ... Read more
19 Feb 2020
•
51mins
2.31 Listener Questions, Responsibility of Reviewers, & Duration of Response with Dr. Bishal Gyawali
2.31 Listener Questions, Responsibility of Reviewers, & Duration of Response with Dr. Bishal Gyawali
This week we answer a few questions: the first is from Patreon backer, Harry Hong, on Kaplan-Meier curves. The second is... Read more
7 Jan 2020
•
40mins